Member Info for RevoltingPeasant

Thanks Munchlet. Encouraging. I need a share price of 2p (pre consolidation) to break even. Lets hope the placing is not too big.

Good to see some action, but is this a good deal? Anyone any idea?

In my experience, most 7AM Monday RNSs are in respect of long planned corporate actions - eg fund raising. Whilst I acknowledge that Avacta have issued some first thing Monday RNSs, I shall not be disappointed if there is nothing at 7AM. I hope the market and share price is equally sanguine.

Shame it had to be Bliar. I can't stand him either.

Enteleon

Are you sure you are right? Surely SENSITIVITY relates to detecting only Covid-19 and not other similar coronaviruses, including the common cold (important as we come into the autumn/winter cold season) and SPCIFICITY is about avoiding false negatives, not false positives. Essential in my view - you can't have people being told they are clear when they are infected, as they can then spead the disease. It matters less if you are told that you are infected when you are not, as if you then isolate you are not spreading the disease.

Or have I got it wrong? Not an expert. Maybe someone who is can put the record straight. Thanks

PS. Either way the higher the percentages the better!

Danaher Q2 results presentation before the US market opens this morning. Press release includes looking forward to Q3 -

"We are tackling the challenges presented by the COVID-19 pandemic head-on, providing critical diagnostic testing capabilities and accelerating our customers' pursuit of new vaccines and treatments. We're fortunate to navigate through this environment from a position of strength and believe that the combination of our team's DBS-driven execution, resilient portfolio and strong balance sheet uniquely position Danaher in 2020 and beyond."

There is a confernce call current (8 to 9AM EST) with sides and a webcast to follow on Danaher's website -

"Danaher will discuss its results during its quarterly investor conference call on July 23, 2020 starting at 8:00 a.m. ET. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available in the same section of Danaher's website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call."

Might be worth checking later.

http://digitaleditions.telegraph.co.uk/data/296/reader/reader.html?social#!preferred/0/package/296/pub/296/page/72/article/63875

Only just got round to reading this.

Under a headline "Prepare for a November nightmare if Covid testing deficiencies aren't fixed" a good William Hague article. Latter part well worth looking at. Coincides with today's CONDOR announcement. The government is desperate to get a reliable "instant test" available for all.

Interview with ME. Not sure it adds much to what we already know, but he does sound confident regarding the future.

https://www.edisongroup.com/edison-tv/nanoco-group-executive-interview-2/27279

Currently sat in a holiday flat overlooking Weymouth Bay. There are 6 cruise ships at anchor in the bay and have been for weeks. The cruise industry will be champing at the bit to get them full of passengers again. Anything that helps them will be seized on, almost irrespective of cost. When you pay considerably more than £100 per day for a cruise, the cost of AVCT's tests - even if taken ever time you board the ship - will fade into insignificance. This is potentially a huge market.

Under a headline "Pre-op rules are keeping people from surgery" - article details pre operative isolation requirements. AVCT's test should see an end to this.

http://digitaleditions.telegraph.co.uk/data/287/reader/reader.html?social#!preferred/0/package/287/pub/287/page/16/article/61085

According to BBC online:

On Sunday Prof Robin Shattock, who is leading research into a vaccine at London’s Imperial College, admitted that the chances of a vaccine being available in September - as ministers had hoped - are now extremely low. And last month Prof Sarah Gilbert, who is leading the UK’s other leading vaccine trial at Oxford University, told the House of Lords Science and Technology committee low transmission rates were also holding up progress for her team.

The problem is that a sufficient number of volunteers have to be exposed to the virus to see whether a vaccine protects them or not. If their chances of being in contact with an infected person are low, it will take a long time to demonstrate the efficacy of a vaccine candidate. Professor Gilbert told the committee: “We now have essentially a very large safety immunogenicity study running in the UK with little chance, frankly, of determining efficacy.”

About 200 groups around the world are working on vaccines and 18 are now being tested on people in clinical trials.

Most experts believe that huge international effort will turn up an effective vaccine – but not before the middle of next year.

Even that would represent a major scientific achievement. There are no guarantees.

Just announced by Oliver Dowden - culture minister - that theatres will shortly have "small pilots of indoor performances with socially distanced audiences ... to help work out the best way to get them up and running" . Is this an opportunity for a John Gore show to be filmed for braodcast by MVR?

In today's Sunday Telegraph business section:

Johnson fires up the engines for Jet Zero future

http://digitaleditions.telegraph.co.uk/data/277/reader/reader.html?social#!preferred/0/package/277/pub/277/page/107/article/58881

Worth a read, but I'm not sure it will significantly impact the share price. But, as they say, all publicity is good publicity. It won't hurt to get VLS better known.

PL ... Don't be such a vanker! No offence intended. Couldn't resist

Here is the cut n paste from IC on-line:

Bango lands Amazon deal with Softbank

Aim-traded Bango (BGO:176p), a provider of a state-of-the-art mobile payment platform enabling smartphone users to charge purchases made in app stores straight to their mobile phone account, has signed a direct carrier billing (DCB) agreement with global technology giant SoftBank (TSE: SOBKY ). It will enable Japanese customers of Amazon (NASDAQ: AMZN) to pay for goods, membership fees and subscription services, and charge the cost to their mobile phone bill.

This means that Bango has DCB for Amazon.co.jp across the three largest operators in what is one of the most highly penetrated mobile markets in the world. The company previously signed deals with NTT Docomo and KDDI in June 2017. Interestingly, Softbank notes that “it looks forward to benefiting from Bango data insights to accelerate the growth of our new business".

That’s important because telecom operators are increasingly looking to capitalise on the data insight into their customers spending habits to deliver a wide range of third-party products and services to them. The tie up with Softbank follows on from a multi-year agreement announced last month with another major global telecoms’ group, highlighting the value of Bango’s technology that enables telecom providers to more efficiently target their customers.

Bango’s share price has almost doubled since I initiated coverage ('Bang on the money', 26 Sep 2016) and has rallied 40 per cent since I last advised buying (‘Capitalise on a big data technology play’, 18 May 2020). Non-executive director Frank Bury is clearly upbeat on trading prospects as he has just snapped up 25,000 shares to lift his stake to 333,500 shares, or 0.45 per cent of the share capital. I see the upside potential, too. That’s because Bango’s market capitalisation of £133m fails to reflect the possibility that the highly operationally geared business could be making cash profits of £10m within a few years assuming current progress is maintained. I edge up my fair value target from 200p to 225p. Buy.

Simon Thompson in IC has today pushed his target price from 200 to 225. May be the cause of the rise.

Timster ... disagree. I think that every company in my portfolio (over 20) issues a statement to coincide with its AGM - usually first thing in the morning (but most AGMs - certainly in "normal" times, ie without Covid-19 distancing measures in force) are in the morning.
13th monkey ... is a delayed statement to allow for something new just coming to fruition today? On the other hand it may be - as you say - wishful thinking.

Is anyone else surprised there has not been a pre AGM statement? Most companies issue and Avacta have in the past. Not too late? RNS at 1pm?

O&W ... we had a similar experience yesterday with a socially distanced BBQ with our daughter and grandchildren. Complete panic when we moved someone else's drinking glass. Separate table for us; separate towel in case we need the loo; hand sanitiser in constant use, etc.. Until there is a reliable point of use test most people will be wary at best, paranoid at worst. AVCT's test is the key to something approaching normality.

Article in today's DT "Covid may not kill cash, but it will change it forever" - http://digitaleditions.telegraph.co.uk/data/261/reader/reader.html?social#!preferred/0/package/261/pub/261/page/100/article/51596.

I can't copy & paste from it, but it refers to digital wallets on phones (and digital currencies) being beneficiaries from stores refusing to accept cash due to C-19. Unless I have misunderstood, could be good for BGO.